What was the market valuation of the US stroke diagnosis-and-treatment market in 2024?

The market valuation was $41.5 Million in 2024. Read More

What is the projected market valuation for the US stroke diagnosis-and-treatment market by 2035?

The projected valuation for 2035 is $69.5 Million. Read More

What is the expected CAGR for the US stroke diagnosis-and-treatment market during the forecast period 2025 - 2035?

The expected CAGR during this period is 4.8%. Read More

Which companies are considered key players in the US stroke diagnosis-and-treatment market?

Key players include Medtronic, Baxter, Boston Scientific, Stryker, Johnson & Johnson, Abbott, Siemens Healthineers, Philips, and GE Healthcare. Read More

What are the market segments for stroke types in the US stroke diagnosis-and-treatment market?

The market segments include Ischemic strokes, Hemorrhagic strokes, and Others. Read More

What were the valuations for Ischemic and Hemorrhagic strokes in 2024?

In 2024, Ischemic strokes were valued at $20.8 Million, while Hemorrhagic strokes were valued at $15.6 Million. Read More

What diagnostic methods are included in the US stroke diagnosis-and-treatment market?

Diagnostic methods include blood tests, computerized tomography scans, magnetic resonance imaging, carotid ultrasound, cerebral angiogram, and echocardiogram. Read More

What was the valuation for magnetic resonance imaging in 2024?

The valuation for magnetic resonance imaging was $12.0 Million in 2024. Read More

What was the valuation for endovascular embolization in 2024?

The valuation for endovascular embolization was $7.0 Million in 2024. Read More

US Stroke Diagnosis and Treatment Market

Q: What treatment types are available in the US stroke diagnosis-and-treatment market?

Available treatment types include Cerebral Thrombosis, Surgical clipping, Endovascular embolization, Angioplasty & stents, and Surgical AVM removal. Read More

US Stroke Diagnosis and Treatment Market Research Report: Size, Share, Trend Analysis By Types (Ischemic strokes, Hemorrhagic strokes, Others), By Diagnosis (Blood tests, Computerized tomography scan, Magnetic resonance imaging, Carotid ultrasound, Cerebral angiogram, Echocardiogram) and By Treatment type (Cerebral Thrombosis, Surgical clipping, Endovascular embolization, Angioplasty & stents, Surgical AVM removal) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

4.8%

2024 Market Size

$ 41.5 Million

2035 Market Size

$ 69.5 Million

Medical Device ● Updated August 2026 Report ID: MRFR/MED/17438-HCR | Pages: 100 | Author: Satyendra Maurya, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Type (USD Million)
  1. 4.1.1 Ischemic strokes
  2. 4.1.2 Hemorrhagic strokes
  3. 4.1.3 Others
2. 4.2 Life Sciences, BY Diagnosis (USD Million)
  1. 4.2.1 Blood tests
  2. 4.2.2 Computerized tomography scans
  3. 4.2.3 Magnetic resonance imaging
  4. 4.2.4 Carotid ultrasound
  5. 4.2.5 Cerebral angiogram
  6. 4.2.6 Echocardiogram
3. 4.3 Life Sciences, BY Treatment Type (USD Million)
  1. 4.3.1 Cerebral Thrombosis
  2. 4.3.2 Surgical clipping
  3. 4.3.3 Endovascular embolization
  4. 4.3.4 Angioplasty & stents
  5. 4.3.5 Surgical AVM removal
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Baxter (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Stryker (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Johnson & Johnson (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Abbott (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Siemens Healthineers (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Philips (NL)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 GE Healthcare (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS
4. 6.4 US MARKET ANALYSIS BY TREATMENT TYPE
5. 6.5 KEY BUYING CRITERIA OF LIFE SCIENCES
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF LIFE SCIENCES
8. 6.8 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
9. 6.9 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 SUPPLY / VALUE CHAIN: LIFE SCIENCES
11. 6.11 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
12. 6.12 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 LIFE SCIENCES, BY DIAGNOSIS, 2024 (% SHARE)
14. 6.14 LIFE SCIENCES, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
15. 6.15 LIFE SCIENCES, BY TREATMENT TYPE, 2024 (% SHARE)
16. 6.16 LIFE SCIENCES, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Stroke Diagnosis and Treatment Market Segmentation

US Stroke Diagnosis and Treatment Market By Type (USD Million, 2025-2035)

Ischemic strokes
Hemorrhagic strokes
Others

US Stroke Diagnosis and Treatment Market By Diagnosis (USD Million, 2025-2035)

Blood tests
Computerized tomography scans
Magnetic resonance imaging
Carotid ultrasound
Cerebral angiogram
Echocardiogram

US Stroke Diagnosis and Treatment Market By Treatment Type (USD Million, 2025-2035)

Cerebral Thrombosis
Surgical clipping
Endovascular embolization
Angioplasty & stents
Surgical AVM removal

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”